ARCHIVES

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

This article is from The Cancer Letter archive.

Vol. 33 No. 02 | January 19, 2007

Download PDF Visit The Full Archive

Related Articles

NCAB Approves Characteristics for Recognition As Comprehensive; Outlook Dim for New Division

May 19, 1989

In Brief: Ashworth Named Center Director at UCSF

March 21, 2014

Five-year Childhood ALL Survival Increased To 90.4 Percent by 2005

March 30, 2012

Clinical Trials: Oncologists, Insurance Executive, Comment On The Results Of Transplant Trials

May 28, 1999

Niccotine Reports As Aiding Metastasis

August 22, 1986

In Brief: Upton Okays Laetrile Clinical Trials, To Seek Protocols From Clinicians For IND Request

October 6, 1978